Bigul

India's Covid-19 vaccination challenge needs a private sector helping hand

The media and opposition figures have justifiably asked why Bharat Biotech's candidate was approved at the same time as AstraZeneca's, when it hasn't even finished or published results from Stage III
05-01-2021
Bigul

Covaxin side effects recorded in real time; efficacy data out soon: Krishna Ella

Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine, Bharat Biotech did not try to supress the side effects of vaccine by giving paracetamol to the volunteers
04-01-2021
Bigul

Covaxin can be back-up if Covishield's efficacy is doubted: AIIMS Director

Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people
03-01-2021
Bigul

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India
03-01-2021

AstraZeneca expects to supply 2 million doses of COVID-19 vaccine every week in UK: Report

The report comes after Britain on Wednesday approved the Oxford-AstraZeneca COVID-19 vaccine, hoping that rapid action will help it stem a record surge of infections driven by a highly contagious form of the virus.
02-01-2021

India likely to have COVID-19 vaccine within days: AIIMS Director

AIIMS Director Dr Randeep Guleria called the approval of the Oxford-AstraZeneca vaccine candidate a "big step forward" not just for India but several parts of the world as well.
31-12-2020
Bigul

Serum Institute vaccine: India may get most of initial 'Covishield' stockpile

Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds
29-12-2020

COVID-19 vaccine by Oxford-AstraZeneca may get Centre's approval in next few days: Report

India may not wait for the regulator in the United Kingdom to approve the Oxford-AstraZeneca COVID-19 vaccine candidate, once evaluation of the data is complete.
28-12-2020
Bigul

World Coronavirus Dispatch: Belarus jails packed with critics and virus

Hong Kong's public sceptical of Chinese vaccines, Sri Lanka's anti-burial rules fan minority ire, AstraZeneca chief feels vaccine will work on variant and other pandemic-related news across the globe
27-12-2020
Next Page
Close

Let's Open Free Demat Account